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Abstract  29 
 30 
The association of neuroanatomical progression with cognitive and clinical deterioration after 31 
first-episode of psychosis remains uncertain. This longitudinal study aims to assess whether 32 
i)impaired executive functioning and emotional intelligence at first presentation are 33 
associated with progressive prefrontal and orbitofrontal cortical thinning ii)negative 34 
symptom severity is linked to progressive prefrontal cortical thinning. 1.5T MRI images were 35 
acquired at baseline and after 3.5 years for 20 individuals with first-episode psychosis and 18 36 
controls. The longitudinal pipeline of Freesurfer was employed to parcellate prefrontal cortex 37 
at two time points. Baseline cognitive performance was compared between diagnostic groups 38 
using MANCOVA. Partial correlations investigated relationships between cognition and 39 
negative symptoms at baseline and cortical thickness change over time. Patients displayed 40 
poorer performance than controls at baseline in working memory, reasoning/problem solving 41 
and emotional intelligence. In patients, loss of prefrontal and orbitofrontal thickness over 42 
time was predicted by impaired working memory and emotional intelligence respectively at 43 
baseline. Moreover, exploratory analyses revealed that the worsening of negative symptoms 44 
over time was significantly related to prefrontal cortical thinning. Results indicate that specific 45 
cognitive deficits at the onset of psychotic illness are markers of progressive neuroanatomical 46 
deficits and that worsening of negative symptoms occurs with prefrontal thickness reduction 47 
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1. Introduction  62 
Patients experiencing their first-episode of psychosis display cognitive impairments 63 
compared with healthy controls across different domains, such as verbal learning, executive 64 
functions, general intelligence, social cognition, attention and working memory (Aas et al., 65 
2014; Kenney et al., 2015). Recent findings have identified executive impairments as one of 66 
the most central deficits in patients with schizophrenia (Chan et al., 2006a, 2006b; Orellana 67 
and Slachevsky, 2013). In neuropsychology, the term executive function is used to indicate 68 
higher-order cognitive processes, which enable people to control and plan their behaviours. 69 
This set of cognitive abilities includes planning, working memory, attention, problem solving, 70 
verbal reasoning, inhibition, mental flexibility and monitoring of actions (Chan et al., 2008). 71 
Neuroimaging, neuropsychological and lesion studies have shown that optimal executive 72 
functioning depends on healthy prefrontal cortex (Gazzaniga, 2004).  73 
In this study, we focused our analyses on cortical thickness, given that it is highly 74 
heritable and driven by specific cellular mechanisms (Panizzon et al., 2009). It therefore 75 
represents an important measure for the identification of prognostically meaningful 76 
biological markers in patients experiencing their first-episode of psychosis. Longitudinal 77 
studies of patients following their first-episode of psychosis have reported progressive 78 
cortical changes, including cortical volume loss in frontal regions (Arango et al., 2012; Pina-79 
Camacho et al., 2016; Roiz-Santiáñez et al., 2014), which may be attributable to reduced 80 
cortical thickness. Cortical thinning over time in frontal and prefrontal regions has been 81 
widely reported in patients with established schizophrenia and first-episode of psychosis 82 
compared with controls (Gutiérrez-Galve et al., 2015; Nesvåg et al., 2008). Janssen et al’s 83 
study identified bilateral cortical thinning in the superior prefrontal cortex in patients with 84 
early-onset first-episode psychosis (Janssen et al., 2009).  85 
The relationship between cortical thickness and cognition has been explored in some 86 
longitudinal studies. Specifically, reductions of cortical thickness in patients with 87 
schizophrenia have been shown to relate to executive functioning (Ehrlich et al., 2012; Geisler 88 
et al., 2015). Less improvement over time in general cognitive performance has been 89 
demonstrated to correlate with a greater longitudinal volume loss in frontal regions, 90 
particularly medial frontal gyrus and inferior frontal gyrus, in patients with first-episode of 91 




experiencing their first-episode of psychosis and 25 healthy controls, found that low working 93 
memory at baseline predicts frontal and parietal cortical thinning 2 years later (Gutiérrez-94 
Galve et al., 2015).  95 
Although executive dysfunction reflects a cognitive impairment and negative 96 
symptoms are a characteristic of schizophrenic illness, these two indices of dysfunction tend 97 
to overlap and are associated with similar behaviours, such as incongruous emotional 98 
responses, reductions in speech, impaired attention and loss of spontaneity (Orellana and 99 
Slachevsky, 2013). Cross-sectional studies tend to report a significant correlation between 100 
executive impairment and negative symptoms in schizophrenia (Bagney et al., 2013; 101 
Nieuwenstein et al., 2001) and first-episode of psychosis (Faerden et al., 2009). The large 102 
ENIGMA cross-sectional meta-analysis reported a significant association between prefrontal 103 
thinning and negative symptom severity in schizophrenia, specifically in the left medial 104 
orbitofrontal cortex, left lateral orbifrontal gyrus and left pars opercularis (Walton et al., 105 
2018). This relationship has also been explored using a longitudinal design, with reports that 106 
less improvement in negative symptoms was significantly correlated with volume loss in 107 
middle and inferior frontal gyrus over time (Asami et al., 2012). These studies emphasise how 108 
both negative symptoms and executive dysfunction can occur with abnormalities in 109 
prefrontal regions.   110 
Emotional intelligence, a domain of social cognition, has also been reported to be 111 
impaired in patients experiencing their first-episode of psychosis compared with healthy 112 
volunteers (Healey et al., 2016; Kenney et al., 2015). Emotional intelligence is a subset of 113 
social intelligence described by Salovey and Mayer (1990) as the ability to monitor one’s own 114 
and others’ feelings and emotions, to discriminate among them and to use this information 115 
to guide one’s thinking and actions’ (Salovey and Mayer, 1990). The prefrontal cortex plays 116 
an important role in the regulation of emotional processing (Forbes and Grafman, 2010); in 117 
particular the orbitofrontal cortex is implicated in emotional and social cognition (Beer et al., 118 
2006; Nestor et al., 2013), while emotional intelligence is reduced in those with lesions in the 119 
right orbitofrontal cortex (Barbey et al., 2014).  120 
 Although several studies have investigated the cross-sectional relationship between 121 
cognition, cortical thickness and clinical symptoms in first-episode psychosis, few have carried 122 




longitudinal design offers an excellent opportunity to explore whether impaired executive 124 
functioning and negative symptom severity at the onset of psychosis (markers of a potentially 125 
more severe illness process) are predictors of prefrontal cortex thinning in subsequent years; 126 
and also to clarify whether impaired emotional intelligence at onset of psychosis is associated 127 
with loss of orbitofrontal cortical thickness over time. We considered that more severe 128 
executive dysfunction and negative symptoms at baseline would be associated with more 129 
progressive neuroanatomical changes and hypothesize three associations: (1) that 130 
performance in those executive functions tests showing an impairment in patients at baseline 131 
compared to healthy controls will be significantly associated with loss of thickness in total 132 
prefrontal cortex in patients over time; (2) impaired emotional intelligence at baseline will be 133 
associated with orbitofrontal cortex thinning in patients as the illness progresses; and (3) 134 
severity of negative symptoms at baseline will be associated with prefrontal cortical thinning 135 
in patients over time. Additionally, through exploratory analyses, we investigated the 136 
relationship of cognitive and clinical change over time with prefrontal cortical thickness 137 
















2. Methods and materials 151 
2.1 Participants 152 
As reported in our previous study (Kenney et al., 2015), 23 individuals in their first-episode of 153 
psychotic illness  and 21 healthy controls participated at both baseline and follow-up in clinical 154 
and cognitive assessments. Of these, 20 patients and 18 healthy controls also participated in 155 
MRI scanning and were included in the present study. The recruitment and clinical assessment 156 
of participants was previously described in detail (Kenney et al., 2015; McFarland et al., 2013; 157 
Scanlon et al., 2014). Exclusion criteria for all participants included neurological disorders, 158 
learning disability, life-time substance dependence, a history of head injury resulting in loss 159 
of consciousness for over 5 minutes, oral steroid use in the previous 3 months and general 160 
MRI contraindications. Exclusion criteria for controls included also a personal or family history 161 
of psychosis or affective disorder. The study was approved by the Research Ethics Committees 162 
of the National University of Ireland Galway and Galway University Hospital. Fully informed 163 
written consent was obtained for all participants.  164 
2.2 Neuropsychological assessment 165 
The MATRICS Consensus Cognitive Battery (MCCB) (Nuechterlein et al., 2008) was used to 166 
assess patients and controls at baseline and follow-up. MCCB was chosen for its excellent test-167 
retest reliability and minimal practice effects (Nuechterlein et al., 2008). Within the MCCB, 168 
only the tests assessing specific domains of executive functions were utilised in the analyses. 169 
Following the definition of executive functioning as set of abilities, presented by Chan et al., 170 
(2008), we were able to cover the following domains: working memory (Wechsler Memory 171 
Scale (WMS®-III): Spatial Span forward and backward and Letter Number Span); attention 172 
(Continuous Performance Test (CPT): Identical Pairs); fluency (Category fluency: Animal 173 
Fluency) and reasoning & problem solving (Neuropsychological Assessment Battery (NAB): 174 
Mazes). Emotional intelligence was measured using the Mayer-Salovey-Caruso Emotional 175 
Intelligence Test (MSCEIT): Managing Emotions. A detailed description of the 176 







2.3 Clinical assessment 181 
Patients were diagnosed using the Structured Clinical Interview for the Diagnostic and 182 
Statistical Manual of Mental Disorders IV text revision version at both timepoints. The 183 
antipsychotic medication taken by patients was recorded and the total dose converted to 184 
chlorpromazine (CPZ) equivalents (Lehman and Steinwachs, 1998; Woods, 2003). The severity 185 
of negative and positive symptoms was assessed at both timepoints using the 0-6 point 186 
Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987). Our interest was specifically 187 
directed to negative symptoms. The original PANSS negative symptom subscale contains two 188 
items better considered to be part of the cognitive domains: “Stereotyped Thinking” and 189 
“Difficulty in Abstract Thinking” (Daniel, 2013; Emsley et al., 2003). We therefore organised 190 
the Negative Subscale according to the Five-Factor solution where Blunted Affect, Emotional 191 
Withdrawal, Poor Rapport, Passive Withdrawal, Lack of Spontaneity, Motor Retardation and 192 
Active Social Avoidance were the included items (Lehoux et al., 2009). Social, occupational 193 
and psychological functioning of patients was assessed using a Global Assessment Functioning 194 
score (Hall, 1995) at both time points.  195 
2.4 MRI data acquisition 196 
MRI images were acquired for all participants at baseline and follow-up at University Hospital 197 
Galway in a 1.5 Tesla Siemens Magnetom Symphony scanner (Erlangen, Germany) equipped 198 
with a 4-channel head coil. A magnetisation prepared rapid gradient echo sequence was used 199 
to generate high-resolution volumetric T1-weighted images with the following parameters: 200 
repetition time=1140 ms, echo time=4.38 ms, inversion time=600 ms, flip angle=15°, matrix 201 
size=256 x 256: slice thickness=0.9 mm and in plane resolution=0.9 mm x 0.9 mm.        202 
2.5 MRI processing 203 
Volumetric T1-weighted images were intensity inhomogeneity corrected using non-204 
parametric, non-uniform intensity normalisation (N3) (Sled et al., 1998) as previously 205 
described (Ahmed et al., 2015; Scanlon et al., 2014). The longitudinal stream (Reuter et al., 206 
2012) of Freesurfer v.5.3.0 (“FreeSurfer,” 2013) was employed to parcellate prefrontal 207 
cortical regions at two time points. This technique has sufficient sensitivity and reliability for 208 
small sample sizes and uses a robust and inverse consistent registration method to create an 209 
unbiased within-subject anatomical template, overcoming the risk of underestimating change 210 




2010). The processing pipeline included skull-stripping (Ségonne et al., 2004), Talairach 212 
transformation, subcortical gray/white matter segmentation according to the Desikan-213 
Killiany atlas (Desikan et al., 2006; Fischl et al., 2002), intensity normalization (Sled et al., 214 
1998), tessellation of the gray/white matter boundaries, automated topological correction 215 
(Fischl et al., 2001; Ségonne et al., 2007) and surface deformation following intensity 216 
gradients in the subject template (Dale et al., 1999). At each step, the output was visually 217 
inspected, and if necessary corrected according the protocol (“FreeSurfer Quality Control 218 
Guide,” 2013). The selection of subregions of the prefrontal cortex (Carlen, 2017) included 219 
the following bilaterally: superior frontal gyrus; middle frontal gyrus subdivided into rostral 220 
and caudal division; inferior frontal gyrus subdivided into pars opercularis, triangularis and 221 
orbitalis; orbito frontal subdivided into lateral and medial division and frontal pole. These 222 
regions were all added to create a total prefrontal cortical region of interest (ROI) (Figure 1A). 223 
The orbitofrontal ROI was created by adding the lateral and medial orbitofrontal subregions 224 
(Figure 1A). Lastly, the thickness, defined as the average distance between the gray-white 225 
boundary and the pial surface within each ROI, was extracted at baseline and follow-up for all 226 
the regions of interest for all the patients. 227 
2.6 Statistical analysis 228 
2.6.1 Clinical and demographics 229 
All analyses were carried out with the Statistical Package for the Social Sciences version 23 for 230 
Windows. Shapiro-Wilk Test was used to test for normal distribution of each cognitive, clinical 231 
and neuroimaging variable. Outliers were defined as greater or less than 3 by standard 232 
deviation from the mean. Age, years of education, gender, time between scanning and 233 
cognitive testing were compared between groups using t-test, chi-square and Mann-Whitney 234 
Test. Differences between baseline and follow-up on clinical variables were tested using 235 
Wilcoxon Signed-ranks Test and Paired-Sample T-test. Raw scores of the cognitive tests for 236 
both patients and controls were age and gender corrected using normative data previously 237 







2.6.2 Cognitive impairment at baseline & prefrontal cortical thickness change over time 242 
One-way MANCOVA was used to compare executive functioning and emotional intelligence 243 
performance at baseline between patient and control groups, covarying for years of 244 
education. Partial correlation, covarying for age, gender and intracranial volume (ICV), was 245 
used to assess associations between the tests showing impairment in executive functioning 246 
and emotional intelligence in patients at baseline and total prefrontal and orbitofrontal 247 
thickness change respectively. Change in neuroanatomical measures was expressed using the 248 
following formula: 
𝐹𝑜𝑙𝑙𝑜𝑤−𝑢𝑝 − 𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒  
𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒
× 100. In the case of statistically significant 249 
correlation with total prefrontal cortex, post-hoc analysis assessed whether cognitive 250 
impairment at baseline significantly correlated with specific subregions.  251 
2.6.3 Negative symptoms severity at baseline & prefrontal cortical thickness change over time 252 
Partial correlation was used to assess association between negative symptoms severity at 253 
baseline and total prefrontal cortical thickness in patients. Age, gender and ICV were added 254 
as confounding variables. Change in neuroanatomical measures was expressed using the 255 
following formula: 
𝐹𝑜𝑙𝑙𝑜𝑤−𝑢𝑝 −𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒  
𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒
× 100.   256 
2.6.4 Cognitive and clinical change & prefrontal cortical thickness change 257 
Partial correlation was used to explore the relationship between cognitive and clinical change 258 
(Follow-up−Baseline) with prefrontal cortical thickness progression over time 259 
(
𝐹𝑜𝑙𝑙𝑜𝑤−𝑢𝑝 − 𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒  
𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒
× 100) in patients. Post-hoc analysis was carried out to clarify which 260 
specific prefrontal cortical subregions were involved. Given the exploratory nature of the 261 
analyses, all the results were corrected for multiple comparisons, using the Benjamini-262 
Hochberg procedure with α= 0.05, which decreases the false discovery rate (Benjamini and 263 








3. Results 269 
Patient and control groups were matched for gender, age, time between scans and predicted 270 
IQ, measured using the national adult reading test (Table 1). Years of education was 271 
significantly different between patients and controls and was included as a covariate in all 272 
analyses. Patients significantly improved over time in positive, general and total score in the 273 
PANSS scale (Table 2). Global assessment of functioning strongly improved 3.5 years following 274 
the first-episode of psychosis. At the follow-up time point, patients were diagnosed with 275 
schizophrenia (n=5), schizoaffective disorder (n=3), delusional disorder (n=1), psychotic 276 
disorder not otherwise specified (n=3), bipolar type I (n=6) and psychotic depression (n=2).  277 
3.1 Groups Differences at Baseline in Cognition 278 
There was a significant difference between patients and controls at baseline when 279 
considering jointly the six cognitive measures Wilk’s Λ F(6,30)= 4.823, p= <.001. For executive 280 
functioning patients scored significantly worse than controls in Category Fluency: Animal 281 
fluency, CPT: Identical Pairs, WMS: Spatial Span and NAB: Mazes and not WMS: Letter 282 
Number Span. Patients’ performance in MSCEIT: Managing Emotions was significantly worse 283 
compared with controls (Figure 1B, table 3).   284 
3.2 Executive Impairment & Prefrontal Cortical Thickness 285 
In the patient group, change in total prefrontal cortical thickness, specifically loss of thickness 286 
over time, was significantly associated with impaired working memory: spatial span at 287 
baseline (r=0.517; p=0.040, Figure 1C). Post-hoc analysis conducted to determine the 288 
prefrontal subregions involved in the patient group revealed a significant involvement of 289 
rostral middle frontal cortex (r=0.546; p=0.029) and the frontal pole (r=0.507; p=0.045). 290 
However, this association lost significance after correcting for multiple comparisons [rostral 291 
middle frontal & frontal pole (p=0.245; p=0.245)].  No significant correlation was found 292 
between total prefrontal cortical thickness change and the remaining impaired executive 293 
functioning tests (r-range=-0.064 − 0.458; p-range=0.075 − 0.814). In the control group, none 294 
of the executive function measures at baseline (working memory, attention, fluency and 295 
reasoning & problem solving) were significantly correlated with total prefrontal thickness 296 
change over time (r-range=-0.362−0.325; p-range=0.185−0.759). Additionally, the 297 




was significantly different (z=2.28; p=0.02) in patients compared to controls. Exploratory 299 
analyses investigating the relationship between change in cognitive performance and change 300 
in total prefrontal thickness did not reveal any significant associations (r=-0.273−0.327; p= 301 
0.216−0.959).  302 
3.3 Emotional Intelligence Impairment & Orbitofrontal Thickness 303 
When investigating the relationship between emotional intelligence at baseline and 304 
orbitofrontal thickness change, we found that impaired emotional intelligence in the patient 305 
group was a significant predictor of loss of orbitofrontal thickness 3.5 years following the first-306 
episode of psychosis (r=0.512; p=0.042, Figure 1D). Although this significant relationship was 307 
not present in the control group (r=0.178; p=0.542), the difference between the relationships 308 
in patients and controls was not statistically significant (z=1.09; p=0.138).  309 
3.4 Negative Symptoms & Prefrontal Cortical Thickness 310 
The severity of negative symptoms at illness onset was not significantly related to total 311 
prefrontal thickness change over time (r= -0.095; p=0.717). However, our exploratory analysis 312 
after correcting for multiple comparison revealed that change in negative symptoms was 313 
strongly correlated with reduction of total prefrontal cortical thickness over time (r=-0.627; 314 
p=0.007, Figure 2A). This association remained significant after controlling for both positive 315 
symptoms change and total medication intake (r=-0.553; p=0.032). Specifically we found the 316 
involvement of medial orbitofrontal (r=-0.721; p=0.01, Figure 2B), caudal (r=-0.659; p=0.01) 317 
and rostral anterior cingulate (r=-0.604; p=0.02), and rostral middle frontal cortex (r=-0.695; 318 
p=0.01); with the exception of pars triangularis (r=-0.519; p= 0.07) which did not survive 319 
multiple comparison correction. When using the standard negative subscale of the PANSS, 320 
our results were very similar: correlation between change in negative symptoms and change 321 
in total prefrontal cortical thickness was significant (r=-0.644; p=0.005), with the involvement 322 
of medial orbitofrontal (r=-0.721; p=0.002), caudal (r=-0.659; p=0.002) and rostral anterior 323 
cingulate (r=-0.604; p=0.002), and rostral middle frontal (r=-0.695; p=0.035). These 324 
correlations were present even though the difference between negative symptoms at 325 






4. Discussion 329 
In this study, consistent with the extant literature we found that patients in their first-330 
episode of psychotic illness perform significantly worse on several tests assessing different 331 
aspects of executive functions compared to healthy controls, including category fluency, 332 
attention, working memory and reasoning & problem solving (Holmén et al., 2012; Leeson et 333 
al., 2010; Perez-Iglesias et al., 2010; Zabala et al., 2010). Of these executive functioning 334 
impairments and consistent with our first hypothesis, we found that poorer performance at 335 
baseline in spatial working memory was a significant predictor of loss of total prefrontal 336 
cortical thickness in the initial years after illness onset. Furthermore, this relationship 337 
between cognitive function and brain change was not found in the control group, consistent 338 
with a disorder-related pathological process marked by working memory dysfunction and 339 
underpinning cortical thinning over time. Working memory has been considered a central 340 
component of executive functioning since they share a large proportion of common variance 341 
(McCabe et al., 2010; Zillmer & Spiers, 2001) and the nature of executive functions in 342 
controlling and monitoring information is intertwined with the function expressed by working 343 
memory, understood as dynamic manipulation of contents (Miyake et al., 2000). Our finding 344 
is consistent with that of Gutierrez-Galve et al’(2015), which reported that poor working 345 
memory present at the time of the first assessment in first-episode of psychosis patients was 346 
associated with frontal cortical thinning after 2 years (Gutiérrez-Galve et al., 2015). In an 18 347 
years longitudinal study on first-episode of schizophrenia patients, working memory was also 348 
found to be associated with frontal grey and white matter loss (Andreasen et al., 2011). In a 349 
healthy control study, low working memory performers showed significantly less surface area 350 
in the inferior, superior frontal gyrus and medial orbitofrontal gyrus compared to high 351 
working memory performers (Nissim et al., 2017).  352 
Although post-hoc results did not survive multiple comparisons and require replication, we 353 
detected relationships between impaired working memory at baseline and thinning of the 354 
rostral middle frontal gyrus and frontal pole over time. The contribution of the dorsolateral 355 
prefrontal cortex to optimal functioning of spatial working memory has been extensively 356 
reported in both human and non-human primates (Goldman-rakic, 1996). The involvement 357 
of mid-dorsolateral frontal cortex has been demonstrated when the working memory task 358 




patients with schizophrenia, greater dysfunction in the physiological activation of the 360 
dorsolateral prefrontal cortex has been linked to poorer working memory performance 361 
(Perlstein et al., 2001). Bertolino and colleagues reported that in schizophrenia the functional 362 
integrity of neurons within the dorsolateral prefrontal cortex has also predictable 363 
physiological impacts throughout the entire working memory cortical network (Bertolino et 364 
al., 2000). Our study additionally identified a significant relationship between impaired 365 
working memory at baseline and frontal pole thinning. The activation of the lateral 366 
frontopolar area during working memory tasks has been also reported in meta-analysis based 367 
on healthy controls (Bludau et al., 2014). 368 
We also found impairment of emotional intelligence at baseline in individuals 369 
experiencing first-episode of psychosis compared to controls, as demonstrated by other 370 
studies focusing on schizophrenia (Dawson et al., 2012; Frajo-apor et al., 2017). Impaired 371 
emotional intelligence was significantly associated with a reduction of orbitofrontal thickness 372 
over time in patients after their first-episode of psychosis, supporting our second hypothesis. 373 
Orbitofrontal cortex is an area crucial for the generation of emotions that guide interpersonal 374 
behaviour (Beer et al., 2006) and critical for emotional processes, given its connection to the 375 
limbic system (Krueger et al., 2009; Nestor et al., 2013). Nestor and colleagues reported that 376 
subregions of orbitofrontal cortex were involved in performance on behavioural measures of 377 
various aspects of social cognition (Nestor et al., 2013). In schizophrenia middle prefrontal 378 
abnormality has been linked to emotional attribution deficit (Yamada et al., 2007). 379 
The neurobiological mechanism that underlies the progressive loss of prefrontal thickness 380 
is still unknown, although some evidence suggests that neuropil pruning could be the cause 381 
of this progressive reduction of grey matter in schizophrenia (Selemon and Goldman-rakic, 382 
1999). Reduced N-acetyl aspartate (NAA), which is an amino acid involved in the synthesis 383 
pathway of glutamate and used as a marker of neural viability, is reduced in prefrontal regions 384 
in schizophrenia (Abbott and Bustillo, 2006) and in the left frontal lobe of patients at risk of 385 
developing schizophrenia (Jessen et al., 2006). NAA reduction might be due to reduced 386 
neuropil, as indicated by post-mortem studies (Selemon and Goldman-rakic, 1999). Although 387 
the pathogenetic mechanisms underlying neuropil reduction requires further clarification, we 388 
speculate that cognitive deficits, such as spatial working memory and emotional intelligence 389 




neuroprogressive process culminating in loss of cortical thickness as the illness progresses. 391 
Spatial working memory impairment has been also presented as an effective endophenotypic 392 
marker for schizophrenia (Glahn et al., 2003) and significantly associated with a major 393 
candidate gene: Disrupted in Schizophrenia-1 (DISC-1) (Carless et al., 2011). The variation in 394 
DISC1 sequence seems to affect both neuroanatomy and cognition; Vázquez-bourgon et al.’s 395 
study showed the potential role of this gene in modulating longitudinal cortical thinning in 396 
patients suffering from a first-episode of non-affective psychosis, especially prominent in the 397 
frontal cortex (Vázquez-bourgon et al., 2016).  398 
Whilst on the one hand, our findings show that cognitive deficits at the onset of psychotic 399 
illness are associated with progressive prefrontal cortical thickness reduction, our exploratory 400 
analysis failed to find any association between change in cognitive performance and change 401 
in total prefrontal thickness, as reported elsewhere (Gutiérrez-Galve et al., 2015). The 402 
executive functioning and emotional intelligence impairment remain stable in patients, 403 
without showing a significant worsening over time compared to controls (Table 2). These 404 
findings suggest that cognitive impairment at onset of psychosis represents a trait marker and 405 
that the progressive neuroanatomical thinning over time in the prefrontal cortex does not 406 
mediate cognitive deterioration. 407 
Our study failed to find any significant association between severity of negative symptoms 408 
at illness onset and total prefrontal thickness change, thus rejecting our third hypothesis. In 409 
contrast, our exploratory analysis revealed that the clinical observation of worsening negative 410 
symptoms is indeed associated with total prefrontal thickness reduction over time. When 411 
exploring which prefrontal subregions were involved, we found thickness reduction in caudal 412 
and rostral anterior cingulate, medial orbitofrontal and rostral middle frontal cortex. A 4-year 413 
longitudinal study based on 24 patients with chronic schizophrenia and 25 controls found that 414 
greater negative symptoms severity was associated with faster rates of frontal and temporal 415 
brain volume changes, indicators of faster deterioration (Mathalon et al., 2001). In a voxel-416 
based morphometry 1.5-year longitudinal study on first-episode schizophrenia, Asami et 417 
colleagues reported that less improvement in negative symptoms, assessed with Brief 418 
Psychiatric Rating Scale, was correlated with more longitudinal loss, in inferior and superior 419 
frontal gyrus (Asami et al., 2012). Negative symptom severity in a large ENIGMA study was 420 




2018). Other longitudinal studies failed to find any association over time (Cobia et al., 2012; 422 
Gutiérrez-Galve et al., 2015). The observation from the current study that prefrontal 423 
neuroanatomical progression more closely aligned with progression of negative symptoms 424 
than of cognitive impairment suggests a progressive pathophysiological process plays an 425 
important role in the worsening of clinical symptoms.  426 
Strengths and limitations 427 
The main strength of this study is the longitudinal nature of the sample, which can capture 428 
the progression after the first-episode of psychosis of anatomical, cognitive and clinical 429 
variables and their intrinsic relationships. The careful parcellation of prefrontal cortex using 430 
the longitudinal stream of Freesurfer based on an unbiased within-subject anatomical 431 
template (Reuter et al., 2012) allowed us to increase the anatomical sensitivity and hence 432 
better detect anatomical changes over time.  433 
The main weakness of the study is the relatively small sample size, which might have 434 
reduced the power to detect more subtle differences in cognitive, neuroanatomical and 435 
clinical variables. Furthermore, due to the available cognitive battery, we could not assess 436 
two important facets of executive functions, inhibition and switching. In addition, to reduce 437 
multiple analysis we assessed the prefrontal subregions summed bilaterally and did not 438 
explore any lateralised effects or other parts of the brain. We employed a measure of negative 439 
symptoms which excluded cognitive symptoms however alternative measurements of core 440 
negative symptoms incorporating a scale such as SANS (Andreasen, 1989) may have produced 441 
different results (Kirkpatrick et al., 2006).  442 
Conclusion 443 
 This longitudinal study tracking the interplay between neuroanatomy, cognition and 444 
clinical presentation indicates that working memory and emotional intelligence impairment 445 
at the onset of psychotic illness are a trait marker of progressive prefrontal thinning, and that 446 
worsening of negative symptoms is associated with prefrontal thickness reduction as the 447 
illness progresses. These results suggest that there is already a cognitive signature at the 448 
onset of psychosis, which is associated with poorer outcome in terms of other 449 




multimodal assessments and repeated sampling will help to confirm and develop these 451 
findings.  452 
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Figure Legends 760 
 761 
Figure  1  762 
(A)  Sub division of prefrontal cortex based on the Desikan-Killiany atlas. Schematic illustration 763 
of two regions of interest (the subregions were added bilaterally): above total prefrontal 764 
cortex, below orbitofrontal cortex. SFG = superior frontal gyrus; CMF= caudal middle frontal; 765 
RMF= rostral middle frontal; LOF= lateral orbitofrontal; POr= pars orbitalis; PTr= pars 766 
traingularis; POp= pars opercularis; CAC= caudal anterior cingulate; RAC= rostral anterior 767 
cingulate; FP= frontal pole; MOF= medial orbitofrontal. (B) Graphic representation of 768 
differences between groups on cognition at baseline. Legend: FEP= first-episode of psychosis 769 
patients; HC= healthy controls; WMS= Wechsler Memory Scale; NAB= Neuropsychological 770 
Assessment Battery; MSCEIT= Mayer-Salovey-Caruso Emotional Intelligence Test. Note: years 771 
of education included in the model as covariate; *=significant group difference. (C) Partial 772 
correlation between working memory: spatial span at baseline in patients and percentage of 773 
total prefrontal thickness change. (D) Partial correlation between emotional intelligence at 774 
baseline in patients and percentage of orbitofrontal thickness change. Note: years of 775 
education, age, gender and ICV included as covariates in all the correlations. 776 
Figure 2 777 
(A) Partial correlation between negative symptoms change and percentage of total prefrontal 778 
thickness change. (B) Partial correlation between negative symptoms change and percentage 779 
of thickness change in medial orbito frontal region, the strongest correlation among all the 780 










 Table 1. Demographic characteristics of the participants. 788 
 789 
 790 
  791 




Test statistic / p-value
Gender N (m/f) 13/7 10/8 X
2
= 0.35 / 0.552 
Age at onset (mean years ± SD) 24.9 ± 9.2 
 
 
Age Baseline (mean years ± SD) 28.1 ± 8.1 30.3 ± 7.6 t= 0.85 / 0.399 
Age Follow-Up (mean years ± SD) 32.8 ± 8.0 33.7 ± 7.8 t= 0.36 / 0.724 
Education (mean years ± SD) 15.7 ± 2.8 18.1 ± 2.9 t= 2.60 / 0.014 
Time between Scans (mean years ± SD) 3.6 ± 1.0 3.2 ± 1.2 *U= 129.50 / 0.141 
NART (Predicted IQ) (mean score ± SD) 112.9 ± 8.0 114.9 ± 7.2 t= 0.83 / 0.416 






















 Baseline Follow-up Test statistic / p-
value   
 Mean ± SD Mean ± SD  
Duration of untreated psychosis 
(DUP)(months) 
12.9    
Positive and negative Syndrome 
scale 
   
PANSS positive score 17.2 ± 4.1 10.4 ± 3.7 *z= -3.41 / 0.001 
PANSS negative score 14.1 ± 4.8 12.0 ± 6.8 *z= -1.57 / 0.115 
Negative factor 
according to Five Factor 
solution 
6.7 ± 4.7 5.75 ± 6.6 *z= -0.78 / 0.438 
PANSS general score 31.2 ± 4.3 23.3 ± 6.3  *z= -3.23 / 0.001 
PANSS total score 62.5 ± 8.1 45.6 ± 14.7  *z= -3.46 / 0.001 
Functionality    
Global assessment of     
functioning 
52.0 ± 10.8 72.0 ± 15.5   *z= -3.83/ >0.001 
Neuropsychological measures    
Category Fluency 48.9 ± 11.7 55.9 ± 9.9 *z=-0.15/0.879 
CPT: Identical Pairs  42.0 ± 11.2 50.9 ± 8.3 t= -2.27/ 0.035 
WMS: Spatial Span 41.4 ± 10.0 49.9 ± 9.1 t=-1.12/0.275 
Letter Number Span 42.2 ± 8.8 47.5 ± 4.8 t= 1.92/0.071 
NAB: Mazes 39.3 ± 7.4 43.1 ± 9.4 t= -2.22/0.039 
MSCEIT: Managing 
Emotions 
45.5 ± 13.0 55.5 ± 9.7 t= -1.36/0.190 
Medication (N)    
Antipsychotics 19 13  
Mood stabilisers 0 2  
Anti-depressants 6 4  
No medication 1 9  
  Chlorpromazine equivalent 
daily dose 
204.0 ± 226.3 175.0 ± 276.8 *z= -0.92 / 0.355 
  Chlorpromazine equivalent total 
amount of cumulative dose  
 266642.40 ± 
63246.43 
 
Note: *= variable non-normal distribuited; Medication at baseline= 6 patients were taking antidepressant 
+ antipsychotic medications; 9 patients were taking more than one antipsychotic medication. Medication 
at follow-up= 4 patients were taking more than one antipsychotic medication; 2 patients were taking 
antidepressant + antipsychotic medications. Chlorpromazine equivalent= antipsychotic medication was 















  BASELINE FOLLOW-UP GROUP * TIME 
GLM    F (6,30) p   F (6,30) p F (5,18) p 
    4.82 0.001   4.47 0.002 1.60 0.160 
  FEP HC   FEP HC     
 TEST SCORES USED Mean ± SD Mean ± SD F (1,34) p Mean ± SD Mean ± SD F (1,35) p   
Category fluency Total number of 
animals named 
48.9 ± 11.7 48.9 ± 9.2 4.50 0.041 55.9 ± 9.9 59.9 ± 12.5 12.87 0.001   
CPT: identical pairs Mean d′ value across 
4 conditions 
42.0 ± 11.2 46.5 ± 12.1 6.03 0.019 50.9 ± 8.3 51.7 ± 4.7 3.40 0.089   
WMS: spatial span   Sum of raw scores  
 
41.4 ± 10.0 44.4 ± 13.2 10.16 0.003 49.9 ± 9.1 54.7 ± 9.2 9.98 0.222   
Letter number span Number of correct 
trials 
42.2 ± 8.8 46.7 ± 12.2 3.45 0.072 47.5 ± 4.8 52.7 ± 6.9 4.53 0.115   
NAB: mazes Total raw score 39.3 ± 7.4 43.1 ± 9.4 20.21 <0.001 51.5 ± 8.7 53.3 ± 10.0 8.83 0.201   
MSCEIT: managing 
emotions 
Branch score using 
general consensus  
scoring 
45.5 ± 13.0 48.1 ± 10.3 7.32 0.010 55.5 ± 9.7 52.8 ± 9.7 1.61 0.044   
 
Note: the table shows the difference between FEP group and HC group on tests assessing executive functioning and emotional intelligence at baseline (F(6,30)=4.82,p=0.001), at follow-up 
(F(6,30)=4.47;p=0.002) and over time (F(5,18)=1.60;p=0.160). Legend: FEP= first-episode of psychosis patients; HC= healthy controls; GLM= generalized linear model. CPT= Continuous 
performance Test; WMS= Wechsler Memory Scale; NAB= Neuropsychological Assessment Battery; MSCEIT= Mayer-Salovey-Caruso Emotional Intelligence Test; Test scores used = 
description of test scores used reported in Nuechterlein et al. (2008); d’ value:  ability of the participant to discriminate between signal and noise.  
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